All Stories

  1. Comparison of complete blood count (CBC) parameters in patients with Sanjad-sakati syndrome and healthy controls in Abuzar Hospital, Ahvaz
  2. Altered inflammatory and coagulation markers in women with a history of recurrent pregnancy loss: A case-control study
  3. The role of chemokine receptors in leukemia: implications for prognosis and therapeutic strategies
  4. The role of gene polymorphisms in the susceptibility and therapeutic response of chronic immune thrombocytopenic purpura
  5. Potential Effects of Aspirin on Transcription Factors Related to the Inflammation in Atherosclerosis: A Systematic Review
  6. Evaluation of the effects of silver nanoparticles and ciprofloxacin on apoptotic gene expression (BAX, Bcl-2, and caspase-3) in NALM-6 acute lymphoblastic leukemia progenitor B cells
  7. Indications for Performing the APCA Test in Female Infertility
  8. TNFAIP3 Gene Polymorphisms and the Risk of Thrombocytopenia: A Cross‐Sectional Study in Iranian Population
  9. Investigating the predictive role of inflammatory indices in cancer metastasis
  10. Immune System‐Related Genetic Risk Factors for Inhibitory Antibody Development in Patients With Hemophilia: Reviewing an Old Problem From a New Perspective—A Narrative Review
  11. The role of platelets in the regulation of myeloid-derived suppressor cells in immune thrombocytopenia
  12. Assessment of rs1205 and rs1130864 Polymorphisms of C‐Reactive Protein Gene (CRP) and Serum CRP Levels in Immune Thrombocytopenia: A Case‐Control Study
  13. Update Prognostic Potency of Vascular Endothelial Growth Factor‐A in the Acute Lymphoblastic Leukemia Landscape: A Meta‐Analysis
  14. Missense and nonsense mutations and inhibitor development in patients with hemophilia A and B
  15. The Association of Serum Level of TGF‐β1 and Clinical Manifestations in Sickle Cell Anemia: A Case‐Control Study
  16. Impact of Genetic Polymorphisms on Treatment Outcomes of Proteasome Inhibitors and Immunomodulatory Drugs in Multiple Myeloma
  17. Evaluation of Complete Blood Count Parameters in Patients With Diabetes Mellitus: A Systematic Review
  18. The Association of Nasal and Blood Eosinophils with Serum IgE Level in Allergic Rhinitis and Asthma: A Case‐Control Study
  19. Evaluation of Pro‐BNP biomarker in heart failure patients and its relationship with complete blood count parameters: A case–control study
  20. DNA damage repair in megakaryopoiesis: molecular and clinical aspects
  21. Modification macrophage to foam cells in atherosclerosis disease: some factors stimulate or inhibit this process
  22. The need to establish and recognize the field of clinical laboratory science (CLS) as an essential field in advancing clinical goals
  23. The prognostic potential of long noncoding RNA XIST in cardiovascular diseases: a review
  24. A systematic review of second-generation FLT3 inhibitors for treatment of patients with relapsed/refractory acute myeloid leukemia
  25. Emerging Roles of HOTAIR LncRNA in the Pathogenesis and Prognosis of Cardiovascular Diseases
  26. Association of Free Radical Product and Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis
  27. lncRNA TUG1 as Potential Novel Biomarker for Prognosis of Cardiovascular Diseases
  28. rs1800890 Polymorphism of IL-10 and Susceptibility to Idiopathic Thrombocytopenic Purpura
  29. Regulation and Functions of α6-Integrin (CD49f) in Cancer Biology
  30. Biomarkers of endothelial dysfunction are associated with poor outcome in COVID‐19 patients: A systematic review and meta‐analysis
  31. Association of human papillomavirus with breast cancer: a new perspective on an old debate
  32. Application of Bayesian Decision Tree in Hematology Research: Differential Diagnosis of β-Thalassemia Trait from Iron Deficiency Anemia
  33. Aplastic anemia, cellular and molecular aspects
  34. Aspirin exacerbated respiratory disease (AERD): molecular and cellular diagnostic & prognostic approaches
  35. The effect of inflammatory factors and their inhibitors on the hematopoietic stem cells fate
  36. Platelets in In-stent Restenosis: From Fundamental Role to Possible Prognostic Application
  37. Chemo/radiotherapy-Induced Bone Marrow Niche Alterations
  38. The role of exogenous Fibrinogen in cardiac surgery: stop bleeding or induce cardiovascular disease
  39. Co-existence of mutations in myeloproliferative neoplasms and their clinical significance: a prognostic approach
  40. Prognostic role and therapeutic susceptibility of cathepsin in various types of solid tumor and leukemia: A systematic review
  41. T-Cell Molecular Modulation Responses in Atherosclerosis Anergy
  42. Epigenetic modifications and transcriptional networks in leukemic transformation of HSCs
  43. STAT5: From Pathogenesis Mechanism to Therapeutic Approach in Acute Leukemia
  44. Investigation of JAK2V617F Mutation Prevalence in Patients with Beta Thalassemia Major
  45. Cardiomyopathy in Thalassemia: Quick Review from Cellular Aspects to Diagnosis and Current Treatments
  46. Expression of Blood Cells Associated CD Markers and Cardiovascular Diseases: Clinical Applications in Prognosis
  47. Involvement of circulating inflammatory factors in prognosis and risk of cardiovascular disease
  48. Neutropenia and leukemia development: genetic risk factors and prognosis
  49. Immunomodulation in leukemia: cellular aspects of anti-leukemic properties
  50. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis
  51. Involvement of Interferon‐γ + 874A/T Polymorphism in the Pathogenesis of and Therapeutic Response to Immune Thrombocytopenia
  52. Strategies to inhibit arsenic trioxide‐induced cardiotoxicity in acute promyelocytic leukemia
  53. Role of bone marrow adipocytes in leukemia and chemotherapy challenges
  54. T‐bet transcription factor in cardiovascular disease: Attenuation or inflammation factor?
  55. Endothelial Cells: From Dysfunction Mechanism to Pharmacological Effect in Cardiovascular Disease
  56. Protective role of heat shock transcription factor 1 in heart failure: A diagnostic approach
  57. Signaling-chemokine axis network in brain as a sanctuary site for metastasis
  58. Platelet Activation Polymorphisms in Ischemia
  59. Cellular expression of CD markers in immune thrombocytopenic purpura: implications for prognosis
  60. Role of chemokines in metastatic niche: new insights along with a diagnostic and prognostic approach
  61. Oxidative stress in normal hematopoietic stem cells and leukemia
  62. JAK2V617F allele burden: innovative concept in monitoring of myeloproliferative neoplasms
  63. Cardiovascular disease cause challenge in hematologic cancers
  64. Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response
  65. How is the relationship between TWIST-1 and BCR-ABL1 gene expressions in chronic myeloid leukaemia patients?
  66. Antioxidant and hepatoprotective effects of Capparis spinosa L. fractions and Quercetin on tert-butyl hydroperoxide- induced acute liver damage in mice
  67. Association between gene polymorphisms and clinical features in idiopathic thrombocytopenic purpura patients
  68. BCR/ABL analysis in myelodysplastic syndromes
  69. Restoration of natural killer cell cytotoxicity in the suppressive tumor microenvironment: novel approaches to treat AML
  70. Evaluation of miR-21 and miR-150 expression in immune thrombocytopenic purpura pathogenesis: a case-control study
  71. Expression of CD markers' in immune thrombocytopenic purpura: prognostic approaches
  72. Sex chromosome changes in leukemia: cytogenetics and molecular aspects
  73. Optimizing peripheral blood stem cells transplantation outcome through amend relapse and graft failure: a review of current literature
  74. Association between beta globin haplotypes, HBBP1 and HMOX1 polymorphisms in relation to HbF among sickle cell anemia patients: a study in Southwest Iran
  75. tree-based methods for differential diagnosis of hematologic disorders
  76. An association study between CHEK2 gene mutations and susceptibility to breast cancer
  77. Prognostic significance of aberrant expression of CD markers in acute lymphoblastic leukemia
  78. Crosstalk between catecholamines and erythropoiesis
  79. The role and clinical implications of the endosteal niche and osteoblasts in regulating leukemia
  80. MicroRNAs as prognostic biomarker and relapse indicator in leukemia
  81. PD-1/PD-L1 as a prognostic factor in leukemia
  82. Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2V617F mutations and laboratory findings: a meta-analysis
  83. Association between microRNA-21, microRNA-150, and micro-RNA-451 expression and clinical outcome of patients with acute lymphoblastic leukemia
  84. Analysis of DNA methyltransferase 3A gene mutations in patients with Philadelphia-negative myeloproliferative neoplasms
  85. Role of oxidative stress in liver cancer
  86. Sequencing myeloproliferative leukemia exon 10 mutations in iranian patients with breakpoint cluster region-abelson murine leukemia viral oncogene homolog 1-negative myeloproliferative neoplasm
  87. Bone marrow blood vessels: normal and neoplastic niche
  88. High platelet count and high probability of CALR detection in myeloproliferative neoplasms
  89. Acute myeloid leukemia in the vascular niche
  90. Incidence of T315I mutation in BCR/ABL-positive CML and ALL patients
  91. Regulatory role of Megakaryocytes on Hematopoietic Stem Cells Quiescence by CXCL4/PF4 in Bone Marrow Niche
  92. Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells
  93. Cytogenetic changes of mesenchymal stem cells in the neoplastic bone marrow niche in leukemia
  94. Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis
  95. Role of stem cell factor in the placental niche
  96. Significance of oncogenes and tumor suppressor genes in AML prognosis
  97. A cocktail of repurposed drugs for targeted therapy of glioblastoma
  98. Is Wilms’ tumor gene 1 a useful biomarker for detecting minimal residual disease in chronic myeloid leukemia (BCR-ABL1-p210-positive) patients?
  99. Evaluation of α-Globin Gene Mutations Among Different Ethnic Groups in Khuzestan Province, Southwest Iran
  100. Evaluation of microRNA-146a expression in acute lymphoblastic leukemia
  101. Stem Cell Therapy ‒ Approach for Multiple Sclerosis Treatment
  102. Is There a Relationship Between CXCR4 Gene Expression and Prognosis of Immune Thrombocytopenia in Children?
  103. Signaling and molecular basis of bone marrow niche angiogenesis in leukemia
  104. Coexistence of P190 BCR/ABL transcript and CALR 52-bp deletion in chronic myeloid leukemia blast crisis: a case report
  105. Hepatic metastatic niche: from normal to pre-metastatic and metastatic niche
  106. Prognostic value and clinical significance of TCR rearrangements for MRD monitoring in ALL patients
  107. Survivin and SIRT1: can be two prognostic factors in chronic myeloid leukemia?
  108. Wnt/β-catenin signaling in bone marrow niche
  109. Inhibition of Ras-mediated signaling pathways in CML stem cells
  110. Bone marrow niche in the myelodysplastic syndromes
  111. Central nervous system niche involvement in the leukemia
  112. MicroRNAs in erythropoiesis and red blood cell disorders
  113. Twist as a new prognostic marker in hematological malignancies
  114. The Influence of Polymorphisms in Disease Severity in β-Thalassemia
  115. The bone marrow metastasis niche in retinoblastoma
  116. Immunophenotype, microRNA expression and cytogenetic characterization of acute leukemias of ambiguous lineage
  117. Rare cytogenetic abnormalities and alteration of microRNAs in acute myeloid leukemia and response to therapy
  118. Regulatory effect of chemokines in bone marrow niche
  119. Targeting PI3K/AKT/mTOR network for treatment of leukemia
  120. The mechanistic role of epigenetic in multiple myeloma
  121. Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis
  122. G-CSF induces up-regulation of CXCR4 expression in human hematopoietic stem cells by beta-adrenergic agonist
  123. A case of chronic lymphoblastic leukemia with an abnormal rare karyotype
  124. The role of Pax5 in leukemia: diagnosis and prognosis significance
  125. Hodgkin’s lymphoma after 2-month infliximab therapy: case report
  126. Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches
  127. BRAF mutation in hairy cell leukemia
  128. New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia
  129. PCR Analysis of IgH and TCR-γ Gene Rearrangements as a Confirmatory Diagnostic Tool for Lymphoproliferative Disorders
  130. The role of notch signaling in bone marrow niche
  131. Induction of Fetal Hemoglobin as a Novel Therapeutic Strategy for β-Hemoglobinopathy
  132. Pattern of immunoglobulin and T-cell receptor-δ/γ gene rearrangements in Iranian children with B-precursor acute lymphoblastic leukemia
  133. Frequency of β-Thalassemia or β-Hemoglobinopathy Carriers Simultaneously Affected with α-Thalassemia in Iran
  134. Prooxidant-Antioxidant Balance and hs-CRP in Patients with β-Thalassemia Major
  135. The role of microRNAs in stemness of cancer stem cells
  136. Meta-analysis of Genetic Polymorphisms and Ophthalmologic Disease Risk in Asian Populations: a Case of DNA Repair XRCC1 Gene
  137. Bone marrow neoplastic niche in leukemia
  138. The roles of miR-146a in the differentiation of Jurkat T-lymphoblasts
  139. The Role of the Nervous System in Hematopoietic Stem Cell Mobilization
  140. Does DNA Methylation Plays a Critical Role in Osteoblastic Differentiation of Mesenchymal Stem Cells (MSCs)?
  141. Expressional Correlation of Human Epidermal Growth Factor Receptor 2, Estrogen/Progesterone Receptor and Protein 53 in Breast Cancer
  142. Evaluation of H3 Histone Methylation and Colony Formation in Erythroid Progenitors Treated with Thalidomide and Sodium Butyrate
  143. JAK2 V617F Mutation in Iranian Patients with Myeloproliferative Neoplasms: Clinical and Laboratory Findings
  144. Biology and Bioinformatics of Myeloma Cell
  145. The first report of homozygous May-Hegglin anomaly E1841K mutation